DuoTEN is an innovative and reliable embolization agent formulated to treat a wide range of arterial and venous hemorrhoids, including pelvic, vulvar, gastrointestinal, colon, and anal lesions. By combining DuoTEN with dextrose in a 1:1 or 1:2 ratio (depending on procedural preference), clinicians achieve precise, minimally invasive occlusion of hemorrhoidal vessels—leading to rapid symptom relief and improved patient outcomes. Its easy-to-use design, cost effectiveness, and comfortable application make DuoTEN a trusted choice for healthcare professionals working in various endovascular or proctological settings.
Key Features and Technology
DuoTEN + Dextrose (1:1 or 1:2 Mix)
Safe Embolization: The mixture establishes a reliable occlusive effect on hemorrhoidal vasculature while maintaining control over flow rate.
Adjustable Consistency: Depending on the proportion used, physicians can modulate viscosity for better vessel targeting or extended dwell time.
Effective Arterial & Venous Hemorrhoid Occlusion
Wide Applicability: Addresses an array of hemorrhoid etiologies—pelvic, vulvar, gastrointestinal, colon, and anal manifestations.
Targeted Vascular Shutdown: Localized embolization reduces abnormal blood flow and alleviates patient discomfort quickly.
Innovative & Easy to Use
Straightforward Mixing: Simple ratio-based combination with dextrose ensures minimal preparation time and consistent results.
Minimal Instrumentation: Employs standard endovascular or proctological delivery systems, streamlining procedure steps and lowering resource overhead.
Clinical Advantages & Indications
Minimally Invasive Hemorrhoid Management
Decreased Surgical Burden: May reduce or avoid the need for more extensive surgical procedures, such as hemorrhoidectomy.
Rapid Symptom Relief: Embolization curtails bleeding and discomfort, enabling a quick return to normal activities.
High Efficacy & Patient Comfort
Localized Occlusion: Embolization is restricted to the target vessels, minimizing systemic impact or risk of collateral damage.
Gentle Tissue Interaction: Formulation with dextrose fosters a biologically compatible environment, translating to less postoperative discomfort.
Cost Efficiency
Fewer Resources: By offering a straightforward mixing protocol and single injection, clinicians reduce procedure time and consumables.
Lower Recurrence: Effective occlusion and reduced complication rates can drive down long-term management costs.
Versatile Implementation
Multiple Hemorrhoid Types: Employed for varied hemorrhoidal anatomies (internal, external, vulvar, etc.), ensuring broad clinical utility.
Adapted to Routine Practice: Integrates seamlessly with existing endovascular or proctology-based delivery equipment.
